Skip to content
Screener

MiMedx Group MDXG Total Equity

Total Equity at other companies

IAR
Integra LifeSciencesIART
$1.04B+0.5%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$2.79M+115%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$148.27M-36.4%
Solventum logo
SolventumSOLV
$4.8B+31.7%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$223.84M+14.8%
CorMedix logo
CorMedixCRMD
$437.05M+280%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemJune 30,2026December 31,2025
Total liabilities$64,995$86,105
Stockholders' equity
Common stock; $0.001 par value; 250,000,000 shares authorized; 149,188,840 issued and 145,724,441 outstanding at June 30, 2026 and 148,093,920 issued and outstanding at December 31, 2025149148
Additional paid-in capital297,094299,081
Treasury stock at cost; 3,464,399 shares at June 30, 2026 and 0 shares at December 31, 2025(12,859)
Accumulated deficit(68,381)(42,681)
Total stockholders' equity216,003256,548
Total liabilities and stockholders’ equity$280,998$342,653

Item 1. Financial Statements

FAQ

What is MiMedx Group's total equity?
MiMedx Group (MDXG) reported total equity of $216M in Q2 2026.
How has MiMedx Group's total equity changed year-over-year?
MiMedx Group's total equity decreased by 0.3% year-over-year, from $216.62M to $216M.
What is the long-term trend for MiMedx Group's total equity?
Over 5 years (2020 to 2025), MiMedx Group's total equity has grown at a 343.2% compound annual growth rate (CAGR), from -$150K to $256.55M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about MiMedx Group's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude